Graeme Sloan – Managing Director – Kali Metals (ASX:KM1) is a portfolio of assets that represents one of the largest and most prospective exploration packages across Australia’s world leading hard-rock lithium fields.
Copyright 2024 – Finance News Network
20 Sep 2019 - Prospect Resources Limited (ASX:PSC) Managing Director, Sam Hosack provides an update on the company's Arcadia lithium project in Zimbabwe, including advanced negotiations with a number of African and international banks on funding.
28 Oct 2024 - Australia's Chief Scientist, Dr Cathy Foley, AO PSM, presents at the Semiconductor Australia 2024 conference. She highlights Australia’s strengths in tech development and outlines a vision for a sustainable economy led by innovation.
15 Mar 2023 - Lake Resources Limited (ASX:LKE) Managing Director and CEO David Dickson discusses how he ended up at Lake, the company's focus over the last half, building a new team, Lake's technology partner Lilac Solutions, offtake agreements, credit export agencies and operational updates.
21 Feb 2023 - BluGlass Limited (ASX:BLG) President Jim Haden provides an update on the company, discussing the launch of the company's first suite of laser products, integration of the recently acquired fab facility and outlook for 2023.
27 Nov 2020 - East 33 Limited (ASX:E33) Co-founder and Executive Chairman James Garton talks about the company's dominant position as a supplier and distributor of Sydney Rock Oysters, ambitions ahead of its listing on the ASX and the potential of the world-class Sydney Rock Oyster as a luxury food alongside French Champagne or Beluga Caviar.
17 Aug 2022 - CARETEQ Limited (ASX:CTQ) Executive Chairman Mark Simari discusses the company's recent agreement with drug management platform StrongRoom AI and the transition from paper-based to digital record keeping within the aged care and assistive living sector.
06 Apr 2021 - LaserBond Limited (ASX:LBL) CEO Wayne Hooper talks about the company's strong 1H21 results despite the impact of COVID-19, its focus on growth opportunities to expand its national footprint, and business strategy, including potential growth via acquisitions.
25 Mar 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt provides an update on the company's pipeline of clinical trials, focusing on results in head and neck cancer, lung cancer and breast cancer.